As clinicians increasingly encounter patients with IBD as well as obesity, diabetes, or metabolic liver disease, there is a clear need to synthesize what is known about safety, metabolic effects, and IBD-specific outcomes to support evidence-informed clinical decision-making, explains senior investigator and study author Jolle St-Pierre, MD, PhD, FRCPC, a clinical assistant professor in the Division of Gastroenterology and Hepatology at the University of Calgary, Canada, in an email to Gastro Today
Studies suggest that berberine can significantly enhance metabolic health, making it beneficial for individuals managing body mass and blood sugar levels
The most commonly prescribed GLP1 injectable medications in Australia include: Tirzepatide (brand name: Mounjaro KwikPen), which is a dual GIP/GLP1 receptor agonist supplied as a multi-dose pre-filled pen containing four weekly doses per pen
Can I drink alcohol while on Semaglutide